Pregled bibliografske jedinice broj: 523999
Novel biologically active nitro and amino substituted benzimidazo[1,2-a]quinolines
Novel biologically active nitro and amino substituted benzimidazo[1,2-a]quinolines // Bioorganic & medicinal chemistry, 19 (2011), 21; 6329-6339 doi:10.1016/j.bmc.2011.09.002 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 523999 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Novel biologically active nitro and amino substituted benzimidazo[1,2-a]quinolines
Autori
Perin, Nataša ; Uzelac, Lidija ; Piantanida, Ivo ; Karminski-Zamola, Grace ; Kralj, Marijeta ; Hranjec, Marijana
Izvornik
Bioorganic & medicinal chemistry (0968-0896) 19
(2011), 21;
6329-6339
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
benzimidazoles ; benzimidazo[1 ; 2-a]quinolines ; antiproliferative activity ; interaction with ct-DNA ; cytometry analysis
Sažetak
This manuscript described the synthesis and biological activity of novel nitro substituted E-2-styryl-benzimidazoles and E-2-(2-benzimidazolyl)-3-phenylacrylonitriles and nitro and amino substituted benzimidazo[1, 2-a]quinolines (4-5, 6-11, 17-20 and 21-32). All of the compounds showed significant growth inhibitory effect towards five tumor cell lines, whereby the IC50 concentrations of 11, 20, 28, 29, 30, 32 are in the low micromolar range (IC50 = 2 – 19 M). The DNA binding experiments did not show significant affinity of two selected compounds towards ds-DNA. The flow cytometry analysis of potential cell cycle perturbations after the treatment with compounds 9, 11, 25 and 29 demonstrated that all of the compounds (5 μM ≈ IC50) significantly delayed the progression through G1 phase, as demonstrated by the accumulation of cells in G1 phase, accompanied with the reduction of the cell number in the cells in S phase, which does not point to DNA damage as the main mechanism of action. Also, fluorescence microscopy study showed cytoplasmic distribution of the compounds, demonstrating that DNA is not the primary target of compounds. Thus, considerable antiproliferative effects of studied compounds are due to interactions with other biological targets within cells.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)
MZOS-098-0982914-2918 - Dizajn, sinteza i ispitivanje interakcija malih molekula s DNA, RNA i proteinima (Piantanida, Ivo, MZOS ) ( CroRIS)
MZOS-125-0982464-1356 - Novi heterocikli kao antitumorski i antivirusni (pametni) lijekovi (Hranjec, Marijana, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Ivo Piantanida
(autor)
Lidija Uzelac
(autor)
Grace Karminski-Zamola
(autor)
Marijeta Kralj
(autor)
Marijana Hranjec
(autor)
Nataša Perin
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)